Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Farmers Insurance
QuintilesIMS
Argus Health
Merck
Healthtrust
Medtronic
Deloitte

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,270,317

« Back to Dashboard

Summary for Patent: 5,270,317
Title: N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
Abstract:The invention relates to N-substituted heterocyclic derivatives and its salts. These derivatives have the formula ##STR1## in which the substituents are as defined in the specification. Application: Angiotensin II antagonists
Inventor(s): Bernhart; Claude (Saint Gely du Fesc, FR), Breliere; Jean-Claude (Montpellier, FR), Clement; Jacques (Saussan, FR), Nisato; Dino (Saint Georges d'Orques, FR), Perreault; Pierre (Montpellier, FR), Muneaux; Claude (Les Matelles, FR), Muneaux; Yvette (Les Matelles, FR)
Assignee: Elf Sanofi (Paris, FR)
Application Number:07/794,497
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,270,317

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,270,317

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France90 03536Mar 20, 1990
France90 10144Sep 01, 1990
France91 11161Sep 10, 1991

International Family Members for US Patent 5,270,317

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan H04506222 ➤ Try a Free Trial
Czechoslovakia 9100745 ➤ Try a Free Trial
Czech Republic 287064 ➤ Try a Free Trial
Czech Republic 287225 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Covington
Fuji
Cipla
Queensland Health
Medtronic
McKinsey
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.